GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (OTCPK:MEPTF) » Definitions » Cyclically Adjusted Revenue per Share

Medipost Co (Medipost Co) Cyclically Adjusted Revenue per Share : $0.00 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medipost Co Cyclically Adjusted Revenue per Share?

Note: As Cyclically Adjusted Revenue per Share is a main component used to calculate Cyclically Adjusted PS Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medipost Co's adjusted revenue per share for the three months ended in Mar. 2024 was $1.747. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Medipost Co's average Cyclically Adjusted Revenue Growth Rate was 1.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medipost Co was 6.60% per year. The lowest was 4.70% per year. And the median was 6.10% per year.

As of today (2024-06-12), Medipost Co's current stock price is $44.99. Medipost Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.00. Medipost Co's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medipost Co was 31.22. The lowest was 2.40. And the median was 10.94.


Medipost Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Medipost Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co Cyclically Adjusted Revenue per Share Chart

Medipost Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medipost Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medipost Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Medipost Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipost Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medipost Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medipost Co's Cyclically Adjusted PS Ratio falls into.



Medipost Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medipost Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.747/118.8477*118.8477
=1.747

Current CPI (Mar. 2024) = 118.8477.

Medipost Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.200 99.353 1.435
201409 1.262 99.608 1.506
201412 1.933 99.098 2.318
201503 1.283 99.720 1.529
201506 1.303 100.050 1.548
201509 1.012 100.110 1.201
201512 0.853 100.220 1.012
201603 0.870 100.560 1.028
201606 0.782 100.790 0.922
201609 0.772 101.460 0.904
201612 0.747 101.560 0.874
201703 1.103 102.850 1.275
201706 1.380 102.610 1.598
201709 1.059 103.490 1.216
201712 1.341 102.990 1.547
201803 1.388 104.100 1.585
201806 1.306 104.130 1.491
201809 1.260 105.650 1.417
201812 1.251 104.350 1.425
201903 1.406 104.490 1.599
201906 1.246 104.880 1.412
201909 1.204 105.200 1.360
201912 1.209 105.120 1.367
202003 1.296 105.540 1.459
202006 1.260 104.870 1.428
202009 1.298 106.200 1.453
202012 1.506 105.765 1.692
202103 1.486 107.357 1.645
202106 1.591 107.579 1.758
202109 1.456 108.759 1.591
202112 1.609 109.676 1.744
202203 1.625 111.806 1.727
202206 1.611 114.083 1.678
202209 1.508 114.831 1.561
202212 1.651 115.200 1.703
202303 1.732 116.550 1.766
202306 1.656 117.140 1.680
202309 1.685 119.111 1.681
202312 1.686 118.848 1.686
202403 1.747 118.848 1.747

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Medipost Co  (OTCPK:MEPTF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medipost Co was 31.22. The lowest was 2.40. And the median was 10.94.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medipost Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Medipost Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipost Co (Medipost Co) Business Description

Industry
Traded in Other Exchanges
Address
21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (Medipost Co) Headlines

No Headlines